EIF3A and diffuse large B-cell lymphoma: Overall, our results demonstrated that low-expressed eIF3a was related to more activated immune microenvironment such as immune response and inflammatory cells activation, which might partially explain the mechanism underlying the prognostic role of eIF3a in DLBCL patients.